GYN-AIDE: AI-Driven Education to Help Gynecologic Cancer Patients
Official title: GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education
Run by University of Southern California · NCT07279571 · Data updated 2026-11-12
This study tests an AI chatbot to help endometrial cancer patients learn about care and HPV vaccination, and to see if using the chatbot influences vaccination uptake in a gynecologic oncology clinic.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 48 (estimated) |
| Sponsor | University of Southern California Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | June 12, 2026 |
| Main results expected | June 9, 2027 |
| Study ends | June 9, 2028 |
| Registry record updated | August 6, 2026 |
| Trial ID | NCT07279571 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) seen in the LA General gynecologic oncology clinic who speak English or Spanish and are willing to consent; eligible for HPV vaccination (pilot intervention age under 46).
✕Probably not a fit
Patients who do not wish to use AI education or who are not eligible for HPV vaccination may not experience additional benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study explores how patients with gynecologic disease obtain cancer-care information and their satisfaction with AI-based education. It has two aims: first, to test an AI chatbot for HPV vaccine counseling and measure patient satisfaction, and second, to see if introducing the chatbot affects HPV vaccination rates among new gynecologic oncology patients. Participants complete surveys to describe their information sources, experiences with the chatbot, and attitudes toward artificial intelligence in education. Eligible participants include adults seen at the LA General gynecologic oncology clinic who speak English or Spanish and provide informed consent. The study is non-interventional and conducted at Los Angeles General Medical Center with USC as lead sponsor and NCI collaboration.
Why it matters
Potential benefit: If successful, patients may receive clearer information and higher HPV vaccination rates through AI-assisted counseling.
How similar studies have gone: Prior work has shown AI-based educational tools can impact patient knowledge and engagement, but results vary by setting and condition, making this approach exploratory in this specific gynecologic oncology context.
Who can join: the full rules
Show full inclusion / exclusion criteria
AI-chatbot Evaluation (Aim 1): Inclusion Criteria: * Patient of the LA General gynecologic oncology clinic * Age 18 years or older * Previously obtained the HPV vaccination (initial chatbot evaluation) * Eligible for HPV vaccination (pilot intervention; age \<46) * Willing and able to provide informed consent Exclusion Criteria: * Patients who do not speak English or Spanish * Patients who do not provide informed consent HPV vaccination rate (Aim 2): Inclusion Criteria: * Patient of the LA General gynecologic oncology clinic * Age 18 years or older * Obtained the HPV vaccine Exclusion Criteria: * None
Where it's running
-
Los Angeles General Medical Center
Los Angeles, California, United States Recruiting
Study contacts
- Principal investigator: Xiaoyue M Guo — University of Southern California
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Awareness and help-seeking for gynecological problems in Hong Kong
This project tries to see if awareness, knowledge, and help-seeking differ between women with gynecological conditions and the general public in Hong Kong using a questionnaire.
-
Molecular and cellular analysis of uterine lavage from gynecologic surgery
This will try a new uterine lavage catheter to collect samples from up to 50 adults having gynecologic surgery to see what cells are present.
-
Cabergoline plus coasting to reduce ovarian hyperstimulation syndrome
This test checks whether adding cabergoline to coasting lowers the chance of ovarian hyperstimulation syndrome in women at high risk during gonadotropin ovarian stimulation.
-
Gynecological Ultrasound Image Bank for Diagnostics and AI
This project will collect gynecological ultrasound images from adult patients at a Rome hospital to build a large database for clinician training, research, and AI diagnostic tools.
-
Immune cells in the uterine lining
This project will test whether the types of immune cells in blood match the immune cells in the uterine lining in women aged 18–45 with unexplained infertility, recurrent miscarriage, or other benign gynecologic reasons who are having an endometrial biopsy.
-
Using ultrasound to assess body composition in critically ill patients
This study is testing if ultrasound can help doctors see changes in body composition, like muscle loss and fluid shifts, in critically ill patients to improve their recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.